Business model IV: Digital revolution company

Thursday June 27th, 09:00 - 10:30


myTomorrows, a new business model for good
myTomorrows is a technology platform that helps the millions of patients left without treatment options every year to navigate and access promising drugs, currently locked away in development. (And we are always looking for talent…..)

About Steve Glass

Steve Glass

COO, myTomorrows
Steve joined the Pharmaceutical Industry as a sales representative after leaving university in the UK. He quickly moved into marketing and management roles in the UK before his first senior international assignment as Country Manager, Portugal for Schering-Plough. He has held senior international roles for major pharma and biotech companies, such as Biomarin, Altana (now part of Takeda) and the Clinigen Group. He has also advised Edmond de Rothschild Partners on private equity pharma transactions. He now is the COO of the Dutch based tech enabled life science company, myTomorrows; a company fundamentally changing the way patients access medicines in development.

Jumpstart your career

Join BioBusiness Summer School to jumpstart your career in Life Sciences by gaining knowledge of business aspects such as product development, IPR, finance and business models. The next edition of the summer school will be organised from 24-28 June 2019 in Amsterdam, the Netherlands.

Why participate

The BioBusiness Summer School is a programme tailored to bridge the gap. By immersing yourself in the business aspects of Life Sciences during this programme, you will learn the basic knowledge of BioBusiness, gain insight in the world of Life Sciences companies, meet leading business leaders and increase your international network.

Employers meet talent

Is your organisation interested in early-career talents in Life Sciences? BioBusiness Summer School can get you in touch with business oriented PhDs, postdocs or Master students. More info can be found here.